Alexza Pharmaceuticals has announced the appointment of Michael S. Holfinger as Vice President, Manufacturing & Global Supply Chain Management. Holfinger was most recently Vice President, Manufacturing & CMC Development at Affymax. Alexza recently announced that Teva will market the company’s Adasuve inhaled loxapine in the US.
Holfinger commented, “With the recent approval of Adasuve in the US and EU, and commercial partnerships in place with Teva and Grupo Ferrer, it is an exciting time to join Alexza. I look forward to working with Alexza’s talented team in optimizing the manufacturing capabilities and supply management systems to ensure the continuous availability of Adasuve to clinicians and patients.”
Alexza President and CEO Thomas King said, “We are very pleased to welcome Mike to our management team. Mike brings a large set of relevant experiences and skills in the areas of commercial manufacturing and global supply chain management. We look forward to his contributions as we escalate the production of Adasuve for the upcoming launches of our first product.”
Read the Alexza press release.
